Want to see JP:6092 full AI Analyst Report?
6092 Stock Chart & Stats
¥598.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥598.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥550.00 - ¥1,009.00
Previous CloseN/A
Volume5.80K
Average Volume (3M)33.86K
Market Cap
¥6.53B
Enterprise Value¥12.54K
Total Cash (Recent Filing)¥4.04B
Total Debt (Recent Filing)¥10.65B
Price to Earnings (P/E)11.7
Beta0.34
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.12%
Share Statistics
EPS (TTM)32.70
Shares Outstanding8,175,200
10 Day Avg. Volume18,510
30 Day Avg. Volume33,860
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.67
Price to Sales (P/S)0.49
P/FCF Ratio51.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained double-digit revenue growth indicates solid demand and expanding business activity. If maintained, this scale can support operating leverage and improve earnings quality once cost pressures and pricing or mix challenges are addressed.
Improved Operating PerformanceThe improvement in gross and operating margins suggests that underlying operations retain some ability to absorb cost pressure and benefit from scale. This provides a foundation for future profitability recovery, despite weak net earnings currently.
Expanded Equity And Asset BaseGrowth in equity and assets indicates that the company has expanded its operating base and retains a workable balance sheet. This supports continued investment and business growth, although leverage limits the flexibility of that foundation.
Bears Say
Sharp Profitability CompressionFalling net margins and a decline in net income despite higher sales point to rising costs, weaker pricing, or unfavorable mix. Persistent compression would reduce the benefit of revenue growth and weaken the company’s ability to reinvest.
Elevated LeverageDebt exceeding equity increases financial risk while returns are already compressed. Higher leverage can constrain investment, raise sensitivity to earnings weakness, and reduce management’s flexibility to navigate prolonged margin pressure.
Volatile Free Cash FlowUneven cash generation and weak conversion of earnings indicate working-capital swings or substantial investment needs. Limited free cash flow can restrict debt reduction, shareholder returns, and funding for future expansion.
EnBio Holdings, Inc. News
6092 FAQ
What was EnBio Holdings, Inc.’s price range in the past 12 months?
EnBio Holdings, Inc. lowest stock price was ¥550.00 and its highest was ¥1009.00 in the past 12 months.
What is EnBio Holdings, Inc.’s market cap?
EnBio Holdings, Inc.’s market cap is ¥6.53B.
When is EnBio Holdings, Inc.’s upcoming earnings report date?
EnBio Holdings, Inc.’s upcoming earnings report date is Nov 18, 2026 which is in 62 days.
How were EnBio Holdings, Inc.’s earnings last quarter?
EnBio Holdings, Inc. released its earnings results on Aug 14, 2026. The company reported ¥36.74 earnings per share for the quarter.
Is EnBio Holdings, Inc. overvalued?
According to Wall Street analysts EnBio Holdings, Inc.’s price is currently Overvalued.
Does EnBio Holdings, Inc. pay dividends?
EnBio Holdings, Inc. pays a Annually dividend of ¥24 which represents an annual dividend yield of 1.12%. See more information on EnBio Holdings, Inc. dividends here
What is EnBio Holdings, Inc.’s EPS estimate?
EnBio Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EnBio Holdings, Inc. have?
EnBio Holdings, Inc. has 8,175,200 shares outstanding.
What happened to EnBio Holdings, Inc.’s price movement after its last earnings report?
EnBio Holdings, Inc. reported an EPS of ¥36.74 in its last earnings report. Following the earnings report the stock price went up 2.246%.
Which hedge fund is a major shareholder of EnBio Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:6092
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
EnBio Holdings, Inc.
EnBio Holdings, Inc. engages in the provision of soil pollution countermeasure services. It operates through the following segments: Soil Pollution Countermeasures, Brownfield Utilization, and Natural Energy. The Soil Pollution Countermeasures segment offers risk consulting services including investigation and construction of countermeasures for soil pollution. It also imports and sells equipment and purifying chemicals used for in situ investigation and purification. The Brownfield Utilization segment manages the buying, restoration, and reselling of contaminated lands. The Natural Energy segment handles the sale of power from natural energy. The company was founded on June 23, 1999 and is headquartered in Tokyo, Japan.
Technical Analysis
Paraca Inc.
―
SHIKIGAKU Co., Ltd.
―
Nakabayashi Co., Ltd.
―
PHYZ Holdings, Inc.
―
Biken Techno Corporation
―